Therapeutic Options for Adult T-Cell Leukemia/Lymphoma
Therapeutic Options for Adult T-Cell Leukemia/Lymphoma
About this item
Full title
Author / Creator
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
Adult T-cell leukemia/lymphoma (ATL) is the first human malignancy associated with a retroviral infection and occurs in approximately 5 % of the 15 million to 20 million people infected by human T-cell lymphotropic virus 1. In general, ATL is resistant to chemotherapy, and while awaiting new therapeutics, patients commonly face a detrimental progre...
Alternative Titles
Full title
Therapeutic Options for Adult T-Cell Leukemia/Lymphoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1432622109
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1432622109
Other Identifiers
ISSN
1523-3790
E-ISSN
1534-6269
DOI
10.1007/s11912-013-0332-6
